# FDA recall D-1281-2020

> **Jubilant Cadista Pharmaceuticals, Inc.** · Class III · drug recall initiated 2020-05-26.

## Product

Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA, For repackaging by: AvKare Inc., Pulaski, TN 38478, Bulk Shipment, NDC 59746-247-97.

## Reason for recall

Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.

## Distribution

TN

## Key facts

- **Recall number:** D-1281-2020
- **Recalling firm:** Jubilant Cadista Pharmaceuticals, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-05-26
- **Report date:** 2020-06-03
- **Termination date:** 2022-11-15

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Salisbury, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1281-2020

## Citation

> AI Analytics. FDA recall D-1281-2020. Retrieved 2026-07-06 from https://api.ai-analytics.org/recall/D-1281-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*